ACO REACH & MSSP
Expert articles and analysis related to aco reach & mssp.
AI Summary — Last 30 Days
In the past 30 days, CMS has underscored its commitment to value-based care through strategic developments surrounding ACO REACH and the impending launch of the LEAD model set for 2027. The LEAD model aims to link quality performance with financial incentives, a significant shift as ACO REACH is expected to sunset at the end of 2026. Concurrently, recent findings suggest that less-efficient ACOs participating in the Medicare Shared Savings Program (MSSP) are more prone to earning bonuses, raising questions about the sustainability and effectiveness of current incentive structures. This dynamic reflects ongoing tensions between quality care delivery and fiscal responsibility in a shifting regulatory landscape, emphasizing the need for ACO leaders and stakeholders to adapt their strategies accordingly. For more insights on this subject, see the commentary on efficiency in MSSP ACOs and the discussion on the LEAD model's impact on quality performance here.
Related Articles
Less-Efficient ACOs Entering Medicare Shared Savings Program More Likely to Earn Bonuses
Q&A: Financial lessons from Northwell’s ACO
As the federal government gears up for another expansion of accountable care organizations (ACOs) and other types of value-based payment, one health system reflected on ways it improved its financial ...
Contributor: REACH Is Delivering Savings—RTA Risk Corridors Put Those Gains at Risk
Terrence Liu, MD,
Closing Perspectives and Future Directions in Multiple Myeloma Care
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
Rebecca Springer post-JPM
From newsletter: Weekly Health Policy Briefing 02/05/25 Weekly Health Policy Briefing 02/05/25 Insights on ACA, VBC, and PACE from public earnings, ACO updates from CMS, and one small step towards sit...
PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success
Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, out...
LEAD: The Big Shift Beyond Attribution and Benchmarks-Quality as a Cash Flow Lever
Quality Risk Under the LEAD Model LEAD (the Long-term Enhanced ACO Design) Model is the Centers for Medicare & Medicaid Innovation Center’s newest accountable care organization (ACO) focused model. Se...